Treatment regimens | COPD | Non-COPD |
---|---|---|
Pembrolizumab + Paclitaxel liposomes + platin | 10 | 19 |
Pembrolizumab + nab‑paclitaxel + platin | 1 | 3 |
Pembrolizumab + Pemetrexed + platin | 2 | 0 |
Nivolumab + Paclitaxel liposome + platin | 2 | 0 |
Tirellizumab + Paclitaxel liposome + platin | 5 | 8 |
Toripalimab +  + Paclitaxel liposome + platin | 1 | 1 |
Sintilimab + Paclitaxel liposome + platin | 3 | 2 |
Sintilimab + Pemetrexed + platin | 0 | 1 |
Camrelizumab + Pemetrexed + platin | 1 | 4 |
Durvalumab + Paclitaxel liposome + platin | 4 | 2 |
Durvalumab + Pemetrexed + platin | 0 | 2 |
Atezolizumab + nab‑paclitaxel + platin | 1 | 1 |
Atezolizumab + Pemetrexed + platin | 0 | 1 |